Antithrombotic strategies in gene therapy

Current Cardiology Reports

Volumn 2, Issue 1, 2000, Pages 34-38

  Channon, Keith M ^a   Annex, Brian H ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; ISOPROTEIN; LYMPHOKINE; NITRIC OXIDE SYNTHASE; VASCULOTROPIN; VASCULOTROPIN A;

ANIMAL; CORONARY ARTERY THROMBOSIS; GENE THERAPY; GENETICS; HUMAN; PATHOLOGY; REVIEW; THROMBOSIS; VASCULAR ENDOTHELIUM; VEIN THROMBOSIS;

ANIMALS; CORONARY THROMBOSIS; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; GENE THERAPY; HUMANS; LYMPHOKINES; NITRIC OXIDE SYNTHASE; PROTEIN ISOFORMS; THROMBOSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VENOUS THROMBOSIS;

EID: 0033649147     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-000-0023-4     Document Type: Article

References (35)

1. The N2-TIL human gene transfer clinical protocol. Hum Gene Ther 1990, 1:73-92.
2. The ADA human gene transfer clinical protocol. Hum Gene Ther 1990, 1:327-362.
3. The GISSI Investigators: Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986, 1:871-874.
4. Campeau L, Enjalbert M, Lesperance J, et al. : Atherosclerosis and the late closure of aortocoronary saphenous vein grafts: sequential studies at 2 weeks, 1 year, 5-7 years, and 10-12 years after surgery Circulation 1983 68(suppl II) II-1-II-7.
5. Channon KM, Fulton GJ, Davies MG, et al. : Modulation of tissue factor protein expression in experimental venous bypass grafts. Atheroscler Thromb Vasc Biol 1997, 17:1313-1319.
6. Jaffe E: The role of blood vessels in hemostasis. In Hematology. Edited by Williams WJ, Erslev AJ, Lichtman MA. New York: McGraw-Hill; 1993:1322-1337.
7. Rade JJ, Schulick AH, Virmani R, Dichek DA: Local adenoviral-mediated expression of recombinant hirudin reduces neointima formation after arterial injury. Nat Med 1996 2:293 298.
8. Pawaske AB, Golino P, Ambrosio G, et al. : A monoclonal antibody against rabbit tissue factor inhibits thrombus formation in stenotic injured rabbit carotid arteries. Circ Res 1994, 74:56-63.
9. Zoldhelyi P, McNatt J, Xu X-M, et al. : Prevention of arterial thrombosis by adenovirus-mediated gene transfer of cyclooxygenase gene. Circulation 1996, 93:10-17.
10. Esmon CT: Thrombomodulin as model of molecular mechanisms that modulate protease specificity and function at the vessel surface. FASEB J 1995, 9:946-955.
11. Kupfer JM, Lei W, Pan T: Adenovirus-mediated gene transfer of thrombomodulin to human endothelial cells: Effects on thromboresistance and in vitro clotting [abstract]. Circulation Suppl 1996, 94:I-741.
12. Carmeliet P, Stassen JM, Van Vlaenderen I, et al. : Adenovirus-mediated transfer of tissue-type plasminogen activator augments thrombolysis in tissue-type plasminogen activator-deficient and plasminogen activator inhibitor-1-overexpressing mice. Blood 1997, 90:1527 1534.
13. Dunn PF, Newman KD, Jones M, et al. : Seeding of vascular grafts with genetically modified endothelial cells. Secretion of recombinant TPA results in decreased seeded cell retention in vitro and in vivo. Circulation 1996, 93:1439-1446.
14. Ekhterae D, Stanley JC: Retroviral vector-mediated transfer and expression of human tissue plasminogen activator gene in human endothelial and vascular smooth muscl cells. J Vasc Surg 1995, 21:953-962.
15. Vassalli G, Dichek DA: Gene therapy for arterial thrombosis. Cardiovasc Res 1997, 35:459 469.
16. Radomski MW, Moncada S: The biological and pharmacological role of nitric oxide in platelet function. Adv Exp Med Biol 1993, 344:251-264.
17. Yan ZQ, Yokota T, Zhang W, Hansson GK: Expression of inducible nitric oxide synthase inhibits platelet adhesion and restores blood flow in the injured artery. Circ Res 1996, 79:38-44.
18. Varenne O, Pislaru S, Gillijns H, et al. : Local adenovirusmediated transfer of human endothelial nitric oxide synthase reduces luminal narrowing after coronary angioplasty in pigs. Circulation 1998 98:919-926.
19. Janssens SP, Bloch KD, Nong Z, et al. : Adenoviral-mediated transfer of the human endothelial nitric oxide synthase gene reduces acute hypoxic pulmonary vasoconstriction in rats. J Clin Invest 1996, 98:317-324
20. Chen AFY, Jiang SW, Crotty TB, et al. : Effects of in vivo adventitial expression of recombinant endothelial nitric oxide synthase gene in cerebral arteries. Proc Natl Acad Sci U S A 1997, 94:12568-12573.
21. Channon KM, Qian HS, Neplioueva V, et al. : In vivo gene transfer of nitric oxide synthase enhances vasomotor function in carotid arteries from normal and cholesterol-fed rabbits. Circulation 1998, 98:1905-1911.
22. Qian HS, Neplioueva V, Shetty GA, et al. : Nitric oxide synthase gene therapy rapidly reduces adhesion molecule expression and inflammatory cell infiltration in carotid arteries of cholesterol-fed rabbits. Circulation 1999, 99: 2979-2982.
23. Kullo IJ, Mozes G, Schwartz RS, et al. : Enhanced endothelium-dependent relaxations after gene transfer of recombinant endothelial nitric oxide synthase to rabbit carotid arteries. Hypertension 1997 30(3 Pt 1):314-320.
24. Kullo IJ, Mozes G, Schwartz RS, et al. : Adventitial gene transfer of recombinant endothelial nitric oxid synthase to rabbit carotid arteries alters vascular reactivity. Circulation 1997, 96 2254-2261.
25. Von der Leyen HE, Gibbons GH, Morishita R, et al. : Gene therapy inhibiting neointimal vascular lesion: In vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci USA 1995, 92:1137-1141.
26. Janssens S, Flaherty D, Nong Z, et al. : Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in rats. Circulation 1998, 97:1274-1281.
27. Matsumoto T, Komori K, Yonemitsu Y, et al. : Hemagglutinating virus of Japan-liposome-mediated gene transfer of endothelial cell nitric oxide synthase inhibits intimal hyperplasia of canine vein grafts under conditions of poor runoff. J Vasc Surg 1998, 27:135 144.
28. Muhlhauser J, Merrill MJ, Pili R, et al. : VEGF165 expressed by a replication deficient recombinant adenovirus vector induces angiogenesis in vivo. Circ Res 1995, 77:1077-1086.
29. Isner JM: Vascular endothelial growth factor: gene therapy and therapeutic angiogenesis. Am J Cardiol 1998, 82 63S-64S.
30. Asahara T, Bauters C, Pastore C, et al. : Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation 1995, 91:2793 2801.
31. Van Belle E, Bauters C, Asahara T, et al. : Endothelial regrowth after arterial injury: from vascular repair to therapeutics. Cardiovasc Res 1998, 38:54-68.
32. Tsurumi Y, Murohara T, Krasinski K, et al. : Reciprocal relation between VEGF and NO in the regulation of endothelial integrity Nat Med 1997, 3:879 886.
33. Spyridopoulos I, Principe N, Krasinski KL, et al. : Restoration of E2F expression rescues vascular endothelial cells from tumor necrosis factor-alpha-induced apoptosis. Circulation 1998, 98:2883 2890.
34. Channon KM, Youngbodd SA, Olmez E, et al. : Acute host-mediated endothelial injury after adenoviral gene transfer: impact on transgene expression and endothelial function. Circ Res 1998, 82:1253 1262.
35. Newman KD, Dunn PF, Owens JW, et al. : Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, an neointimal hyperplasia. J Clin Invest 1995, 96 2955 2965.